FDA provides summaries of adverse drug experiences

被引：0
|
作者：
不详
机构：
来源：
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION | 2008年 / 233卷 / 05期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
引用
收藏
页码：685 / 685
页数：1
相关论文
共 50 条
  • [31] Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
    Wu, Leihong
    Ingle, Taylor
    Liu, Zhichao
    Zhao-Wong, Anna
    Harris, Stephen
    Thakkar, Shraddha
    Zhou, Guangxu
    Yang, Junshuang
    Xu, Joshua
    Mehta, Darshan
    Ge, Weigong
    Tong, Weida
    Fang, Hong
    BMC BIOINFORMATICS, 2019, 20 (Suppl 2)
  • [32] Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
    Leihong Wu
    Taylor Ingle
    Zhichao Liu
    Anna Zhao-Wong
    Stephen Harris
    Shraddha Thakkar
    Guangxu Zhou
    Junshuang Yang
    Joshua Xu
    Darshan Mehta
    Weigong Ge
    Weida Tong
    Hong Fang
    BMC Bioinformatics, 20
  • [33] FDA promotes shorter PMA summaries, faster inspections
    Dickinson, James G.
    Medical Device and Diagnostic Industry, 1998, 20 (12):
  • [34] EFFECTIVENESS OF TRIGGER TOOLS TO DETECT ADVERSE DRUG EVENTS FROM DISCHARGE SUMMARIES: A RETROSPECTIVE STUDY
    Anburaj, E.
    Vilakkathala, R.
    Mallayasamy, S.
    Stanley, W.
    VALUE IN HEALTH, 2016, 19 (07) : A823 - A823
  • [35] DETECTION OF MEDICATION ERRORS IN THE THAI FDA DATABASE OF ADVERSE DRUG REACTIONS REPORTS
    Bunchuailua, W.
    Bunthum, K.
    Poonpanich, N.
    Limpreedeechai, P.
    Angkasirikumjorn, A.
    Suwankesawong, W.
    VALUE IN HEALTH, 2011, 14 (07) : A349 - A349
  • [36] Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database
    Morris, Robert
    Ali, Rahinatu
    Cheng, Feng
    CURRENT DRUG TARGETS, 2024, 25 (07) : 454 - 464
  • [37] Analysis of tolerance to antidepressant drug treatment in FDA Adverse Event Reporting System
    Carnovale, Carla
    Gentili, Marta
    Vigano, Caterina
    Carnaghi, Giulia
    Beltrami, Marta
    Bosi, Monica
    PHARMACOLOGICAL RESEARCH, 2019, 141 : 616 - 617
  • [38] APPARENT INTRACLASS DIFFERENCES IN REPORTS TO THE FDA ADVERSE DRUG REACTION (ADR) DATABASE
    RINSLER, S
    STADEL, B
    HARTER, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (02) : 150 - 150
  • [39] ADVERSE EVENTS ASSOCIATED WITH COLCHICINE DRUG INTERACTIONS: ANALYSIS OF THE PUBLIC VERSION OF THE FDA ADVERSE EVENT REPORTING SYSTEM
    Almalki, Z.
    Guo, J. J.
    Kelton, C. M.
    Wigle, P. R.
    VALUE IN HEALTH, 2013, 16 (03) : A218 - A218
  • [40] Survey of patients' experiences and their certainty of suspected adverse drug reactions
    Narumol, Jarernsiripornkul
    Arunrot, Patsuree
    Krska, Janet
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 168 - 174
12345